JPMorgan Chase & Co
IMUC

JPMorgan Chase & Co’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

JPMorgan Chase & Co’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-439
Closed -$34K – 4084
2013
Q2 		$34K Buy
+439
New +$34K ﹤0.01% 3802